Medical Perception LGBTQ+ Issues Mental Health Healthcare Access Hearing Loss Cognitive Impairment HIV Education Community Health Women's Issues ADHD Awareness Mental Health Stigma Women's Health Issues Women's Health Support Public Health Access to Care Dementia Advocacy Sexual Health
Now under Health Canada review, Gilead is exploring licensing deals to counter its US$28,000 annual cost; global roll-out hinges on affordable generic production.